Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Inventory (2016 - 2020)

Cellectis has reported Inventory over the past 5 years, most recently at $1.6 million for Q4 2020.

  • Quarterly results put Inventory at $1.6 million for Q4 2020, down 44.77% from a year ago — trailing twelve months through Dec 2020 was $1.6 million (down 44.77% YoY), and the annual figure for FY2020 was $1.6 million, down 44.77%.
  • Inventory for Q4 2020 was $1.6 million at Cellectis, down from $2.9 million in the prior quarter.
  • Over the last five years, Inventory for CLLS hit a ceiling of $2.9 million in Q4 2019 and a floor of $118000.0 in Q4 2016.
  • Median Inventory over the past 5 years was $275000.0 (2018), compared with a mean of $1.0 million.
  • Biggest five-year swings in Inventory: soared 953.45% in 2019 and later crashed 44.77% in 2020.
  • Cellectis' Inventory stood at $118000.0 in 2016, then surged by 111.86% to $250000.0 in 2017, then increased by 10.0% to $275000.0 in 2018, then soared by 953.45% to $2.9 million in 2019, then tumbled by 44.77% to $1.6 million in 2020.
  • The last three reported values for Inventory were $1.6 million (Q4 2020), $2.9 million (Q4 2019), and $275000.0 (Q4 2018) per Business Quant data.